Offer - Urjas Oil for just ₹ 1 X
Olmefit H 12.5 Mg/20 Mg Tablet is a prescription drug, available for use as Tablet. Olmefit H 12.5 Mg/20 Mg Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Olmefit H 12.5 Mg/20 Mg Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Olmefit H 12.5 Mg/20 Mg Tablet also has some side effects, the most common being Upper respiratory tract infection. Some other side effects of Olmefit H 12.5 Mg/20 Mg Tablet have been listed ahead. Such side effects of Olmefit H 12.5 Mg/20 Mg Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Olmefit H 12.5 Mg/20 Mg Tablet's effect is Severe during pregnancy and Mild for lactating mothers. It is important to know if Olmefit H 12.5 Mg/20 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olmefit H 12.5 Mg/20 Mg Tablet related warnings section.
Individuals suffering from medical conditions like Asthma, Allergy, Kidney Disease must refrain from the use of Olmefit H 12.5 Mg/20 Mg Tablet since this can cause severe adverse effects. The section on Olmefit H 12.5 Mg/20 Mg Tablet contraindications lists all such conditions.
Drug reaction of Olmefit H 12.5 Mg/20 Mg Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Olmefit H 12.5 Mg/20 Mg Tablet is not safe while driving, and is not addiction.
Olmefit H 12.5 Mg/20 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmefit H 12.5 Mg/20 Mg Tablet safe for pregnant women?
Olmefit H should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Olmefit H 12.5 Mg/20 Mg Tablet safe during breastfeeding?
Side effects of Olmefit H on breastfeeding women are very mild.
What is the effect of Olmefit H 12.5 Mg/20 Mg Tablet on the Kidneys?
Very few cases of side effects of Olmefit H on kidney have been reported.
What is the effect of Olmefit H 12.5 Mg/20 Mg Tablet on the Liver?
Very few cases of side effects of Olmefit H on the liver have been reported.
What is the effect of Olmefit H 12.5 Mg/20 Mg Tablet on the Heart?
Olmefit H is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Olmefit H 12.5 Mg/20 Mg Tablet unless your doctor advises you to do so -
Is this Olmefit H 12.5 Mg/20 Mg Tablet habit forming or addictive?
No, you will not get addicted to Olmefit H 12.5 Mg/20 Mg Tablet.
Interaction between Food and Olmefit H 12.5 Mg/20 Mg Tablet
Taking Olmefit H 12.5 Mg/20 Mg Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olmefit H 12.5 Mg/20 Mg Tablet
Taking Olmefit H 12.5 Mg/20 Mg Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173